Email:  
Monday, March 06, 2006
« Back
Swiss Medica Announces Integrated Partnership with PMS Escape and ChickChat Radio Program
Toronto, Canada – Swiss Medica, Inc. (OTC BB: SWME) is pleased to announce PMS Escape, a patented, clinically proven, all natural supplement, for women with normal PMS-related disturbances in mood and appetite has become a title sponsor of ChickChat Radio. ChickChat Radio is a U.S. nationally syndicated, female-hosted talk radio show for the 25-54 demographic. This multi-media campaign includes product integration into the show, sampling and other giveaways, exclusive podcast sponsorship, 30 and 60 second ads, and website banner advertising.

“We are very excited about this opportunity to market PMS Escape through the ChickChat radio program” said Wendy Kramer, Vice President of Swiss Medica. “Their listening audience is the perfect audience for PMS Escape and the advertisements, contests and sampling are the perfect marketing mix to drive awareness to this customer base. 30 million women in the United States experience what we call ‘mood and food’ disturbances associated with PMS, but some don’t realize the connection between their state of mind and PMS. Our goal is to educate women about PMS, so they can better manage their personal lives and careers. We hope by letting them know that PMS Escape is the only clinically proven, all-natural over-the-counter product available to them, fewer women will experience “mood and food” disturbances.”

“We are thrilled to be working with a company who has a product that can really help our listeners,” said ChickChat co-host Lara Dyan. “Who knew that talking about PMS could be so fun? Let’s face it – when it comes to PMS, if we weren’t laughing we’d be crying!”

“This is a real life issue, and it makes total sense to incorporate it into the real life conversations we have every day at ChickChat,” added co-host Heidi Hanzel.

The PMS-ChickChat partnership was launched several weeks ago, and has already had a positive impact on awareness of PMS Escape and consumer demand.

About ChickChat Radio:

ChickChat Radio is a nationally syndicated, female-hosted talk radio show for the 25-54 demographic. ChickChat is a contemporary, relevant, stylish, unique, non-political, entertaining, not for-women-only radio show hosted by Heidi and Lara -- two women with no loss for words or opinions. Recently honored as 'Rising Stars of Talk Radio' by Radio and Records Magazine, co-hosts Heidi and Lara have also been featured guests on the national Fox News Channel. Their show is broadcast live each weekday with studios in New York City and Washington D.C. ChickChat can be heard on stations nationwide, Sirius Satellite Radio, worldwide via http://www.chickchatradio.com and daily podcasts.



About Swiss Medica, Inc. :

Swiss Medica commercializes clinically tested, patented natural products that relieve chronic ailments. We grow our brands through focused distribution and marketing strategies. Swiss Medica's mission is to be a world leader in the commercialization of safe, effective chronic ailment products that improve quality of lives. Please visit our websites at http://www.swissmedica.com ,www.O24zone.com and http://www.pmsescape.com.

Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used and recommended for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available over-the-counter throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit http://www.O24zone.com, for ordering details and store locators for the nearest pharmacy.

Swiss Medica has recently launching the patented O24 Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia their first NFA Seal of Approval. Over 10 million Americans suffer from the long-term pain associated with Fibromyalgia. In a randomized double blind clinical trial conducted in 2005, 88 per cent of the patients who used O24 Fibromyalgia reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can also visit http://www.O24zone.com, for ordering details and store locators for the nearest retailer.

Swiss Medica also distributes PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: http://www.pmsescape.com for additional information and ordering details.

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to acceptance of Swiss Medica’s products in Canada, the United States and other countries, risks related to international sales and purchases and potential foreign currency exchange fluctuations, acceptance of Swiss Medica's products, increased levels of competition, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.


Contact:
Swiss Medica, Inc.
Investor Relations Contact:
David Jones
(866) 485-4243

OR
Fusion Communications
Media Contact:
Dean Mailey
(604) 218-6767

Posted by ChickChat on March 06, 2006 • Filed Under: PressRelease